20232103

Source:http://linkedlifedata.com/resource/pubmed/id/20232103

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0034380, umls-concept:C0123931, umls-concept:C0205179, umls-concept:C0205195, umls-concept:C0282460, umls-concept:C0701185, umls-concept:C0879262, umls-concept:C1274040, umls-concept:C1527249
pubmed:issue	3
pubmed:dateCreated	2010-6-14
pubmed:abstractText	We carried out this study to examine the health-related quality of life (HRQOL) of patients with advanced colorectal cancer treated with the oral fluoropyrimidine S-1 plus irinotecan (CPT-11).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9616295
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid, http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination), http://linkedlifedata.com/resource/pubmed/chemical/Tegafur, http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1437-7772
pubmed:author	pubmed-author:KusanoMitsuoM, pubmed-author:MatsuiNobuakiN, pubmed-author:NakaoKentaroK, pubmed-author:NaritaKazuhiroK, pubmed-author:TsunodaAkiraA, pubmed-author:TsunodaYukoY, pubmed-author:WatanabeMakotoM, pubmed-author:YasudaNaokuniN
pubmed:issnType	Electronic
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	280-6
pubmed:dateRevised	2011-9-13
pubmed:meshHeading	pubmed-meshheading:20232103-Adenocarcinoma, pubmed-meshheading:20232103-Adult, pubmed-meshheading:20232103-Aged, pubmed-meshheading:20232103-Antimetabolites, Antineoplastic, pubmed-meshheading:20232103-Antineoplastic Agents, Phytogenic, pubmed-meshheading:20232103-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20232103-Camptothecin, pubmed-meshheading:20232103-Colorectal Neoplasms, pubmed-meshheading:20232103-Drug Combinations, pubmed-meshheading:20232103-Female, pubmed-meshheading:20232103-Humans, pubmed-meshheading:20232103-Longitudinal Studies, pubmed-meshheading:20232103-Male, pubmed-meshheading:20232103-Middle Aged, pubmed-meshheading:20232103-Oxonic Acid, pubmed-meshheading:20232103-Quality of Life, pubmed-meshheading:20232103-Questionnaires, pubmed-meshheading:20232103-Tegafur, pubmed-meshheading:20232103-Time Factors, pubmed-meshheading:20232103-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Health-related quality of life in patients with advanced colorectal cancer: results from a phase II study of S-1 combined with irinotecan (CPT-11).
pubmed:affiliation	Department of Surgery, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba, 296-8602, Japan. a.tsunoda@kameda.jp
pubmed:publicationType	Journal Article, Clinical Trial, Phase II